181 related articles for article (PubMed ID: 1830519)
1. Regression of left ventricular hypertrophy in hypertensive heart transplant recipients treated with enalapril, furosemide, and verapamil.
Angermann CE; Spes CH; Willems S; Dominiak P; Kemkes BM; Theisen K
Circulation; 1991 Aug; 84(2):583-93. PubMed ID: 1830519
[TBL] [Abstract][Full Text] [Related]
2. Effect of enalapril on left ventricular mass and performance in essential hypertension.
Grandi AM; Venco A; Barzizza F; Casadei B; Marchesi E; Finardi G
Am J Cardiol; 1989 May; 63(15):1093-7. PubMed ID: 2539714
[TBL] [Abstract][Full Text] [Related]
3. Regression of left ventricular hypertrophy from systemic hypertension by enalapril.
Nakashima Y; Fouad FM; Tarazi RC
Am J Cardiol; 1984 Apr; 53(8):1044-9. PubMed ID: 6322566
[TBL] [Abstract][Full Text] [Related]
4. Wall stress and patterns of hypertrophy in the human left ventricle.
Grossman W; Jones D; McLaurin LP
J Clin Invest; 1975 Jul; 56(1):56-64. PubMed ID: 124746
[TBL] [Abstract][Full Text] [Related]
5. [Regression of hypertensive heart hypertrophy caused by chronic angiotensin-converting enzyme inhibition].
Motz W; Strauer BE
Z Kardiol; 1988 Jan; 77(1):53-60. PubMed ID: 2834885
[TBL] [Abstract][Full Text] [Related]
6. [Effects of verapamil on left ventricular mass and diastolic function in hypertensive patients].
Sau F; Seguro C; Alvau MD; Pargentino E; Cherchi A
Cardiologia; 1993 Nov; 38(11):727-32. PubMed ID: 8004645
[TBL] [Abstract][Full Text] [Related]
7. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial.
Devereux RB; Palmieri V; Sharpe N; De Quattro V; Bella JN; de Simone G; Walker JF; Hahn RT; Dahlöf B
Circulation; 2001 Sep; 104(11):1248-54. PubMed ID: 11551875
[TBL] [Abstract][Full Text] [Related]
8. Favourable interaction of calcium antagonist plus ACE inhibitor on cardiac haemodynamics in treating hypertension: rest and effort evaluation.
Di Somma S; Carotenuto A; de Divitiis M; Paulucci A; Galderisi M; Cuocolo A; de Divitiis O
J Hum Hypertens; 1995 Mar; 9(3):163-8. PubMed ID: 7783096
[TBL] [Abstract][Full Text] [Related]
9. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
[TBL] [Abstract][Full Text] [Related]
10. Preserved ventricular pump function after a marked reduction of left ventricular mass.
Ketelhut R; Franz IW; Behr U; Toennesmann U; Messerli FH
J Am Coll Cardiol; 1992 Oct; 20(4):864-8. PubMed ID: 1356116
[TBL] [Abstract][Full Text] [Related]
11. Influence of verapamil on diastolic left ventricular function in myocardial hypertrophy of different origin.
Hess OM; Murakami T; Krayenbühl HP
Z Kardiol; 1987; 76 Suppl 3():82-6. PubMed ID: 2963452
[TBL] [Abstract][Full Text] [Related]
12. [Circadian behavior of blood pressure and heart rate following orthotopic heart transplantation. Studies before and during antihypertensive therapy].
Angermann CE; Spes CH; Willems S; Dominiak P; Kemkes BM; Theisen K
Z Kardiol; 1989 Apr; 78(4):228-35. PubMed ID: 2544062
[TBL] [Abstract][Full Text] [Related]
13. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
Ketelhut S; Franz IW; Ketelhut RG
High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
[TBL] [Abstract][Full Text] [Related]
14. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.
Wachtell K; Bella JN; Rokkedal J; Palmieri V; Papademetriou V; Dahlöf B; Aalto T; Gerdts E; Devereux RB
Circulation; 2002 Mar; 105(9):1071-6. PubMed ID: 11877357
[TBL] [Abstract][Full Text] [Related]
15. [Effect of enalapril, furosemide and verapamil on cyclosporin concentration in whole blood].
Spes CH; Angermann CE; Anthuber M; Kemkes BM; Theisen K
Klin Wochenschr; 1988 Dec; 66(23):1184-9. PubMed ID: 2850409
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional myocardial responses to chronic treatment with the Ca2+ blocker verapamil (Calan-SR) in hypertensive patients.
Howley JW; Formolo JM; Penney DG
J Cardiovasc Pharmacol; 1993 Oct; 22(4):637-43. PubMed ID: 7505368
[TBL] [Abstract][Full Text] [Related]
17. Effects of graded exercise on blood pressure, heart rate, and plasma hormones in cardiac transplant recipients before and during antihypertensive therapy.
Angermann CE; Spes CH; Dominiak P; Weil J; Gerzer R; Stempfle HU; Kemkes BM; Theisen K
Clin Investig; 1992 Jan; 70(1):14-21. PubMed ID: 1318121
[TBL] [Abstract][Full Text] [Related]
18. Prevention of hypertensive hypertrophy by medical therapy: effects on systolic wall stress and systolic function.
Motz W; Strauer BE
Basic Res Cardiol; 1985; 80(6):642-52. PubMed ID: 2936329
[TBL] [Abstract][Full Text] [Related]
19. The effects of antihypertensive therapy on left ventricular mass in elderly patients.
Schulman SP; Weiss JL; Becker LC; Gottlieb SO; Woodruff KM; Weisfeldt ML; Gerstenblith G
N Engl J Med; 1990 May; 322(19):1350-6. PubMed ID: 2139175
[TBL] [Abstract][Full Text] [Related]
20. Effects of enalapril on left ventricular mass and diastolic function in essential hypertension: special reference to duration of hypertension.
Oki T; Fukuda N; Iuchi A; Tabata T; Sasaki M; Kawahara K; Ishimoto T; Tominaga T; Okushi H; Fujimoto T; Ito S
J Card Fail; 1995 Dec; 1(5):365-70. PubMed ID: 12836711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
